GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...
In the U.S., 25 million people are affected by asthma. That’s roughly 1 in 13 adults and children. Asthma can be mild or severe. Some people with asthma have symptoms every day. Others have symptoms ...
The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...
SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2026In January 2026, it was announced that the European Patent Office (EPO) had declared its intention to grant Iconovo's patent application for ICOpre®.
A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, improved lung function, and reduced attacks. Unlike inhalers, it targets ...
They just won a 2026 HuffPost Shopping Award and they're on a lightning deal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results